PEGylation does not significantly change the initial intravenous or subcutaneous pharmacokinetics or lymphatic exposure of trastuzumab in rats but increases plasma clearance after subcutaneous administration.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Lisa M. Kaminskas Christopher J.H. Porter Charlotte C. Williams Juergen Bulitta David B Ascher |
| Publication date | February 18, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |